Investment and Partnering

Dendright is actively seeking co-development partners to help exploit its platform technology to develop tolerizing therapies against the various applicable autoimmune diseases.

Please contact Dendright for further details on partnering and investment

Helen Roberts, Chief Executive Officer, helen.roberts@dendright.com.au

Dr Craig Belcher, Chairman, craig@dendright.com.au